328 related articles for article (PubMed ID: 24659472)
1. Combined antibacterial effects of tissue-tolerable plasma and a modern conventional liquid antiseptic on chronic wound treatment.
Klebes M; Ulrich C; Kluschke F; Patzelt A; Vandersee S; Richter H; Bob A; von Hutten J; Krediet JT; Kramer A; Lademann J; Lange-Asschenfeld B
J Biophotonics; 2015 May; 8(5):382-91. PubMed ID: 24659472
[TBL] [Abstract][Full Text] [Related]
2. Clinical use of cold atmospheric pressure argon plasma in chronic leg ulcers: A pilot study.
Ulrich C; Kluschke F; Patzelt A; Vandersee S; Czaika VA; Richter H; Bob A; Hutten Jv; Painsi C; Hüge R; Kramer A; Assadian O; Lademann J; Lange-Asschenfeldt B
J Wound Care; 2015 May; 24(5):196, 198-200, 202-3. PubMed ID: 25970756
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the antiseptic efficacy of tissue-tolerable plasma and an octenidine hydrochloride-based wound antiseptic on human skin.
Lademann J; Richter H; Schanzer S; Patzelt A; Thiede G; Kramer A; Weltmann KD; Hartmann B; Lange-Asschenfeldt B
Skin Pharmacol Physiol; 2012; 25(2):100-6. PubMed ID: 22301799
[TBL] [Abstract][Full Text] [Related]
4. Light-activated nanofibre textiles exert antibacterial effects in the setting of chronic wound healing.
Arenbergerova M; Arenberger P; Bednar M; Kubat P; Mosinger J
Exp Dermatol; 2012 Aug; 21(8):619-24. PubMed ID: 22775997
[TBL] [Abstract][Full Text] [Related]
5. Skin disinfection by plasma-tissue interaction: comparison of the effectivity of tissue-tolerable plasma and a standard antiseptic.
Lademann O; Kramer A; Richter H; Patzelt A; Meinke MC; Czaika V; Weltmann KD; Hartmann B; Koch S
Skin Pharmacol Physiol; 2011; 24(5):284-8. PubMed ID: 21709431
[TBL] [Abstract][Full Text] [Related]
6. Antiseptic with modern wound dressings in the treatment of venous leg ulcers: clinical and microbiological aspects.
Sopata M; Kucharzewski M; Tomaszewska E
J Wound Care; 2016 Aug; 25(8):419-26. PubMed ID: 27523653
[TBL] [Abstract][Full Text] [Related]
7. Antiseptic efficacy and tolerance of tissue-tolerable plasma compared with two wound antiseptics on artificially bacterially contaminated eyes from commercially slaughtered pigs.
Hammann A; Huebner NO; Bender C; Ekkernkamp A; Hartmann B; Hinz P; Kindel E; Koban I; Koch S; Kohlmann T; Lademann J; Matthes R; Müller G; Titze R; Weltmann KD; Kramer A
Skin Pharmacol Physiol; 2010; 23(6):328-32. PubMed ID: 20588084
[TBL] [Abstract][Full Text] [Related]
8. Influence of human wound exudate on the bactericidal efficacy of antiseptic agents in quantitative suspension tests on the basis of European Standards (DIN EN 13727).
Radischat N; Augustin M; Herberger K; Wille A; Goroncy-Bermes P
Int Wound J; 2020 Jun; 17(3):781-789. PubMed ID: 32133774
[TBL] [Abstract][Full Text] [Related]
9. Phase IIa randomized, placebo-controlled study of antimicrobial photodynamic therapy in bacterially colonized, chronic leg ulcers and diabetic foot ulcers: a new approach to antimicrobial therapy.
Morley S; Griffiths J; Philips G; Moseley H; O'Grady C; Mellish K; Lankester CL; Faris B; Young RJ; Brown SB; Rhodes LE
Br J Dermatol; 2013 Mar; 168(3):617-24. PubMed ID: 23066973
[TBL] [Abstract][Full Text] [Related]
10. Topical phenytoin versus EUSOL in the treatment of non-malignant chronic leg ulcers.
Carneiro PM; Nyawawa ET
East Afr Med J; 2003 Mar; 80(3):124-9. PubMed ID: 12762426
[TBL] [Abstract][Full Text] [Related]
11. Leg ulcers. Antiseptics and their effect on healing tissue.
Leaper D
Nurs Times; 1986 May 28-Jun 3; 82(22):45-7. PubMed ID: 3636881
[No Abstract] [Full Text] [Related]
12. A randomized-controlled trial comparing cadexomer iodine and nanocrystalline silver on the healing of leg ulcers.
Miller CN; Newall N; Kapp SE; Lewin G; Karimi L; Carville K; Gliddon T; Santamaria NM
Wound Repair Regen; 2010; 18(4):359-67. PubMed ID: 20636550
[TBL] [Abstract][Full Text] [Related]
13. The Management of Critically Colonized and Locally Infected Leg Ulcers with an Acid-Oxidizing Solution: A Pilot Study.
Strohal R; Mittlböck M; Hämmerle G
Adv Skin Wound Care; 2018 Apr; 31(4):163-171. PubMed ID: 29561341
[TBL] [Abstract][Full Text] [Related]
14. Impact of human wound exudate on the bactericidal efficacy of commercial antiseptic products.
Augustin M; Herberger K; Wille A; Twarock S
J Wound Care; 2023 Jul; 32(7):422-427. PubMed ID: 37405941
[TBL] [Abstract][Full Text] [Related]
15. [Prospects for the use of low-temperature gas plasma as an antimicrobial agent].
Ermolaeva SA; Petrov OF; Miller GG; Shaginian IA; Naroditskiĭ BS; Sysoliatina EV; Mukhachev AIa; Morfill GE; Fortov VE; Grigor'ev AI; Gintsburg AL
Vestn Ross Akad Med Nauk; 2011; (10):15-21. PubMed ID: 22168034
[TBL] [Abstract][Full Text] [Related]
16. Tolerability and efficacy of N-chlorotaurine in comparison with chloramine T for the treatment of chronic leg ulcers with a purulent coating: a randomized phase II study.
Nagl M; Nguyen VA; Gottardi W; Ulmer H; Höpfl R
Br J Dermatol; 2003 Sep; 149(3):590-7. PubMed ID: 14510994
[TBL] [Abstract][Full Text] [Related]
17. Review on the efficacy, safety and clinical applications of polihexanide, a modern wound antiseptic.
Hübner NO; Kramer A
Skin Pharmacol Physiol; 2010; 23 Suppl():17-27. PubMed ID: 20829658
[TBL] [Abstract][Full Text] [Related]
18. Eradication of MRSA in chronic wounds of outpatients with leg ulcers is accelerated by antiseptic washes--results of a pilot study.
Reich-Schupke S; Warneke K; Altmeyer P; Stücker M
Int J Hyg Environ Health; 2010 Mar; 213(2):88-92. PubMed ID: 20097610
[TBL] [Abstract][Full Text] [Related]
19. Quality control in chronic wound management: the role of local povidone-iodine (Betadine) therapy.
Daróczy J
Dermatology; 2006; 212 Suppl 1():82-7. PubMed ID: 16490980
[TBL] [Abstract][Full Text] [Related]
20. Suprathel-antiseptic matrix: in vitro model for local antiseptic treatment?
Ryssel H; Andreas Radu C; Germann G; Kloeters O; Riedel K; Otte M; Kremer T
Adv Skin Wound Care; 2011 Feb; 24(2):64-7. PubMed ID: 21242734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
